IL6 and cancer: In the context of chronic inflammation, sustained activation of JAK/STAT3 signaling by canonical pro-inflammatory cytokines, including IL-6, is a biological hallmark of inflammaging and is linked to several age-associated illnesses, including cardiovascular diseases, neurocognitive disorders, and cancer [50–53].